Načítá se...
Nicotinamidephosphoribosyltransferase and cerebral ischemia
Recombinant tissue plasminogen activator is the only drug approved for the clinical treatment of acute ischemic stroke. Thus, there is an urgent unmet need for novel stroke treatments. Endogenous defense mechanisms against stroke may hold the key to new therapies for stroke. A large number of studie...
Uloženo v:
| Vydáno v: | Curr Top Med Chem |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5644507/ https://ncbi.nlm.nih.gov/pubmed/26059356 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|